SCHEMBL4347265

SCHEMBL4347265

C=CCNC(=O)[C@H](O)[C@@H](O)C(=O)NCC=C

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
TSHR P16473 2/20 0.48
ALDH1A1 P00352 5/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
USP2 O75604 1/20 0.46
HPGD P15428 4/20 0.41
HSD17B10 Q99714 1/20 0.41
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
FAAH O00519 1/20 0.39
RAB9A P51151 1/20 0.38
ALPL P05186 1/20 0.38
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL107767 1.00 MAPT (0.48) MAPTSMN1; SMN2TSHRALDH1A1KMT2A
SCHEMBL6890429 1.00 MAPT (0.48) MAPTSMN1; SMN2TSHRALDH1A1KMT2A
SCHEMBL14521227 1.00 MAPT (0.48) MAPTSMN1; SMN2TSHRALDH1A1KMT2A
SCHEMBL15612333 0.91 MAPT (0.45) MAPTSMN1; SMN2TSHRALDH1A1KMT2A
SCHEMBL15612276 0.91 MAPT (0.45) MAPTSMN1; SMN2TSHRALDH1A1KMT2A
SCHEMBL14602769 0.91 MAPT (0.45) MAPTSMN1; SMN2TSHRALDH1A1KMT2A
Acrylamide SCHEMBL9395827 0.89 ALDH1A1 (0.44) MAPTSMN1; SMN2TSHRALDH1A1KMT2A
SCHEMBL9081926 0.89 ALDH1A1 (0.43) MAPTSMN1; SMN2TSHRALDH1A1KMT2A
SCHEMBL15627332 0.85 SMN1; SMN2 (0.48) MAPTSMN1; SMN2TSHRALDH1A1KMT2A
SCHEMBL27958358 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260072020-A1 PRINTABLE MOLECULE-SELECTIVE CORE-SHELL NANOPARTICLES FOR WEARABLE AND IMPLANTABLE SENSING CALIFORNIA INST OF TECHN (US) 2026-03-12 US claimed
EP-4555102-A1 SCALABLE, SUBMICRON-RESOLUTION REPLICATION OF DNA ARRAYS Topogene Inc. (US) 2025-05-21 EP claimed
WO-2024015766-A1 SCALABLE, SUBMICRON-RESOLUTION REPLICATION OF DNA ARRAYS TOPOGENE INC. (US) 2024-01-18 WO claimed
EP-4718055-A2 METHODS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES Yale University (US) 2026-04-01 EP disclosed
US-12578320-B2 Methods and systems for physical expansion and imaging of biological samples YALE UNIVERSITY (US) 2026-03-17 US disclosed
US-20260072020-A1 PRINTABLE MOLECULE-SELECTIVE CORE-SHELL NANOPARTICLES FOR WEARABLE AND IMPLANTABLE SENSING CALIFORNIA INST OF TECHN (US) 2026-03-12 US disclosed
US-12540348-B2 Device and methods of using device for detection of aminoacidopathies UNIVERSITY OF MARYLAND, COLLEGE PARK (US) 2026-02-03 US disclosed
US-20260001997-A1 SULFUR POLYMER IDAHO STATE UNIV (US) 2026-01-01 US disclosed
US-20250244308-A1 METHODS AND SYSTEMS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES UNIV YALE (US) 2025-07-31 US disclosed
WO-2025132508-A1 FIRE-RESISTANT GLAZING SAINT-GOBAIN GLASS FRANCE (FR) 2025-06-26 WO disclosed
WO-2025042943-A2 ULTRASTRUCTURAL MEMBRANE EXPANSION MICROSCOPY MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-02-27 WO disclosed
EP-4117820-A1 METHODS AND SYSTEMS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES Yale University (US) 2023-01-18 EP disclosed
CN-115551638-A Method and system for physical expansion and imaging of biological samples 耶鲁大学 2022-12-30 CN disclosed
US-20220290086-A1 METHODS AND SYSTEMS FOR CELL CULTURE OHIO STATE INNOVATION FOUNDATION (US) 2022-09-15 US disclosed
CN-114381452-A Oligonucleotide separation and purification method 江苏金斯瑞生物科技有限公司 2022-04-22 CN disclosed
CN-104450229-A Special low-temperature-resistant corrosion-resistant crude oil storage tank cleaning agent and preparation method thereof JIANGSU JIANSHEN BIOLOGY AGROCHEMICAL CO LTD 2015-03-25 CN disclosed
US-7576034-B2 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof EKA CHEMICALS AB (SE) 2009-08-18 US disclosed
US-20040260081-A1 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof EKA CHEMICALS AB (SE) 2004-12-23 US disclosed
EP-1427525-A2 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF Chirosep (FR) 2004-06-16 EP disclosed
WO-2003026793-A2 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF EKA CHEMICALS AB (SE) 2003-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001997-A1 SULFUR POLYMER STS, TST, CBS MAPT 2123/4885SMN1; SMN2 176/4885TSHR 3241/4885
US-12578320-B2 Methods and systems for physical expansion and imaging of biological samples KRT18, DSP, SMCHD1 MAPT 352/4885SMN1; SMN2 881/4885TSHR 2214/4885
US-12540348-B2 Device and methods of using device for detection of aminoacidopathies DAO, UROD, ALAD MAPT 4279/4885SMN1; SMN2 3437/4885TSHR 913/4885
US-20260072020-A1 PRINTABLE MOLECULE-SELECTIVE CORE-SHELL NANOPARTICLES FOR WEARABLE AND IMPLANTABLE SENSING MIF, HMOX2, HMOX1 MAPT 3003/4885SMN1; SMN2 2725/4885TSHR 3290/4885
US-20040260081-A1 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof MTCL3, OR10J3, MCM4 MAPT 660/4885SMN1; SMN2 4169/4885TSHR 4882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.